Search clinical trials for: NER1006

Total 15 results

Norgine

Completed

Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults. (MORA)

Colorectal Cancer | Colorectal Carcinoma | Colon Cleansing

United Kingdom, Spain, Belgium, France, Germany, Italy, Poland
Norgine

Completed

Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults (NOCT)

Colon Cancer | Colorectal Carcinoma | Colon Cleansing

United States
Norgine

Completed

Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy

Colon Cancer

Germany
Norgine
Pierrel Research Europe GmbH

Completed

Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects (OUT)

Colorectal Cancer

Romania
Norgine

Completed

Performance of NER1008 Enema Compared With Fleet® Enema in Bowel Cleansing

Colorectal Cancer

United Kingdom
Norgine
Quotient Sciences

Completed

A Pharmacokinetic Study of PLENVU® in Healthy Subjects (PKPU)

Pharmacokinetic

United Kingdom
Nuwacell Biotechnologies Co., Ltd.
Shanghai 6th People's Hospital; Beijing Luhe Hospital

Not yet recruiting

A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA (NCR100)

Knee Osteoarthritis
University of Bologna

Unknown

Colon Cleansing Efficacy With 1L vs. 2L vs. 4L-PEG for Colonoscopy Among Inpatients (INTERPRET)

Colon Disease

Italy
Norgine

Completed

Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.

Colorectal Cancer | Colorectal Carcinoma | Colon Cleansing

Netherlands, United Kingdom, Spain, Germany, Italy, Poland
Serodus ASA
The Research Council of Norway; Smerud Medical Research International AS

Completed

SER100 in Isolated Systolic Hypertension

Isolated Systolic Hypertension

United Kingdom, Finland, Hungary, Norway
Norgine
Xolomon Tree S.L.

Completed

Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia

Colon Cancer | Colon Disease | Colon Cleansing

Spain, Portugal
Neonc Technologies, Inc.

Recruiting

NEO100 and High-Grade Meningioma

Residual, Progressive or Recurrent Grade II or III Meningioma

United States
Neonc Technologies, Inc.

Recruiting

Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

Glioblastoma Multiforme

United States
Neonc Technologies, Inc.

Not yet recruiting

A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

High Grade Glioma | Pineocytoma | Diffuse Midline Glioma, H3 K27M-Mutant | Spinal Cord Tumor | Pediatric Tumor of CNS | Pediatric Tumor of Brain | Pediatric Tumor of Brain Stem | Choroid Plexus Carcinoma, Childhood
Jinling Hospital, China
Jiangsu Synthgene Biotechnology Co.Ltd.

Recruiting

Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer

Pancreatic Cancer

China

3

Subscribe